slides · global inventory
Image
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 119,566
Current window 77,191-77,220
Pages 3,986
Rows per page 30
Component
77,191-77,220 of 119,566
01
Background pattern consists of DNA base pairs (A, C, G, T).23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
04
The chart uses a gradient arrow to emphasize the scale of 12.2M participants compared to other biobanks.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
07
The slide uses a timeline format to demonstrate regulatory milestones and credibility.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
14
Uses a flow diagram to show the gap in healthcare coverage for BRCA testing.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
15
The slide highlights the breadth of genetic reporting and emphasizes FDA authorizations.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
17
The slide highlights the value proposition of the premium subscription tier.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
21
Uses a visual contrast between uniform yellow figures (reactive) and diverse, multi-colored figures (proactive) to illustrate the shift from one-size-fits-all to personalized care.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
24
23andMe | Investor Presentation Deck | 63 slides23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
25
The slide uses a gradient background and visual representations of mobile app screens to illustrate the integration of genetic insights into primary care.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
30
Includes a conceptual diagram of SNP comparison and a multi-level zoom-in Manhattan plot.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
38
The slide uses a three-column process flow to connect market opportunity, genetic validation, and biological mechanism.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
39
The slide uses a biological pathway diagram to explain the mechanism of action for potential combination therapies.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
13
The slide uses a central illustration of a microglial cell with radiating labels describing its functions.Vigil Neuroscience | IPO Presentation Deck | 54 slides · Vigil Neuroscience
Pitch deck Investment bank Beat · Solution1 hit
14
Scientific diagram showing receptor activation upon binding to debris.Vigil Neuroscience | IPO Presentation Deck | 54 slides · Vigil Neuroscience
Pitch deck Investment bank Beat · Solution1 hit
16
Vigil Neuroscience | IPO Presentation Deck | 54 slidesVigil Neuroscience | IPO Presentation Deck | 54 slides · Vigil Neuroscience
Pitch deck Investment bank Beat · Solution1 hit
21
The slide features the company logo and a molecular structure illustration.Vigil Neuroscience | IPO Presentation Deck | 54 slides · Vigil Neuroscience
Pitch deck Investment bank 1 hit
23
The slide uses a 2x2 grid layout to categorize disease information.Vigil Neuroscience | IPO Presentation Deck | 54 slides · Vigil Neuroscience
Pitch deck Investment bank Beat · ProblemLoop · Cost Of Inaction1 hit
24
The diagram shows the molecular mechanism of cell signaling across the cell membrane.Vigil Neuroscience | IPO Presentation Deck | 54 slides · Vigil Neuroscience
Pitch deck Investment bank Beat · ProblemLoop · Cost Of Inaction1 hit
25
The slide uses a comparison matrix to establish a biological rationale for targeting these pathways.Vigil Neuroscience | IPO Presentation Deck | 54 slides · Vigil Neuroscience
Pitch deck Investment bank Beat · ProblemLoop · Cost Of Inaction1 hit
26
The slide uses a causal chain diagram to link genetic mutations to cellular outcomes, supported by empirical data from Kempthorne et al. 2020.Vigil Neuroscience | IPO Presentation Deck | 54 slides · Vigil Neuroscience
Pitch deck Investment bank Beat · ProblemLoop · Cost Of Inaction1 hit
27
Slide 27 of a pitch deck. Contains three distinct chart/image panels showing efficacy of VGL101.Vigil Neuroscience | IPO Presentation Deck | 54 slides · Vigil Neuroscience
Pitch deck Investment bank Beat · ProblemLoop · Cost Of Inaction1 hit
29
Scientific slide presenting microscopy and imaging data (A-D) to support a mechanism of action.Vigil Neuroscience | IPO Presentation Deck | 54 slides · Vigil Neuroscience
Pitch deck Investment bank Beat · ProblemLoop · Cost Of Inaction1 hit
30
The slide uses a combination of longitudinal imaging and scatter/dot plots to establish clinical validity for biomarkers.Vigil Neuroscience | IPO Presentation Deck | 54 slides · Vigil Neuroscience
Pitch deck Investment bank Beat · ProblemLoop · Cost Of Inaction1 hit
32
The slide uses a hierarchical pillar-and-tactic structure to map organizational goals to specific activities.Vigil Neuroscience | IPO Presentation Deck | 54 slides · Vigil Neuroscience
Pitch deck Investment bank 1 hit
35
Vigil Neuroscience | IPO Presentation Deck | 54 slidesVigil Neuroscience | IPO Presentation Deck | 54 slides · Vigil Neuroscience
Pitch deck Investment bank 1 hit
42
Vigil Neuroscience | IPO Presentation Deck | 54 slidesVigil Neuroscience | IPO Presentation Deck | 54 slides · Vigil Neuroscience
Pitch deck Investment bank 1 hit
44
Includes a Manhattan plot (GWAS) and immunohistochemistry images with quantitative analysis of microglia clustering.Vigil Neuroscience | IPO Presentation Deck | 54 slides · Vigil Neuroscience
Pitch deck Investment bank 1 hit
45
Slide contains multiple microscopy images and bar charts showing experimental results from Yuan et al (2016) and Wang et al (2020).Vigil Neuroscience | IPO Presentation Deck | 54 slides · Vigil Neuroscience
Pitch deck Investment bank 1 hit
46
The slide presents histological images and quantitative dot plots comparing Trem2 wild-type, heterozygous, and knockout mice.Vigil Neuroscience | IPO Presentation Deck | 54 slides · Vigil Neuroscience
Pitch deck Investment bank 1 hit
54
Vigil Neuroscience | IPO Presentation Deck | 54 slidesVigil Neuroscience | IPO Presentation Deck | 54 slides · Vigil Neuroscience
Pitch deck Investment bank 1 hit